Tag: patients
Breaking News
AI-Powered Video Generation – A New Revolution – PrimaFelicitas
In recent years, the landscape of digital content creation has undergone significant changes due to the rise of AI-powered video Generation. This innovative technology...
OpenAI claims it can clone a voice from 15 seconds of audio
OpenAI's latest trick needs just 15 seconds of audio of someone speaking to clone that person's voice – but don't worry, no need to...
CMS and Incyte Announce Collaboration and License Agreement for Povorcitinib in China and Southeast Asia
HONG KONG, China and WILMINGTON, Del., Apr 1, 2024 - (ACN Newswire) - China Medical System Holdings Limited (“CMS” or the “Group”) and Incyte (Nasdaq:INCY)...
Eisai Completes Submission of LEQEMBI (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease to the U.S....
TOKYO and CAMBRIDGE, Mass., Apr 1, 2024 - (JCN Newswire) - Eisai Co., Ltd. and Biogen Inc. announced today that Eisai submitted to the...
Voice Engine: OpenAI’s Breakthrough in Synthetic Speech
OpenAI, a prominent artificial intelligence research organization, published a blog post on March 29, discussing their latest development: Voice Engine. This model, created in...
Voice Engine: OpenAI’s Breakthrough in Synthetic Speech
OpenAI, a prominent artificial intelligence research organization, published a blog post on March 29, discussing their latest development: Voice Engine. This model, created in...
Eisai to Divest Rights for Merislon and Myonal in Japan to Kaken Pharmaceutical
TOKYO, Mar 29, 2024 - (JCN Newswire) - Eisai Co., Ltd. announced today that it has entered into an agreement to divest its rights...
Eisai to Divest Rights for Merislon and Myonal in Japan to Kaken Pharmaceutical
TOKYO, Mar 29, 2024 - (JCN Newswire) - Eisai Co., Ltd. announced today that it has entered into an agreement to divest its rights...
Discovery Research on Dual Orexin Receptor Antagonist Lemborexant Honored with PSJ Award for Drug Research and Development 2024
TOKYO, Mar 29, 2024 - (JCN Newswire) - Eisai Co., Ltd. announced today that drug discovery research conducted on lemborexant (brand name: Dayvigo), the...
Discovery Research on Dual Orexin Receptor Antagonist Lemborexant Honored with PSJ Award for Drug Research and Development 2024
TOKYO, Mar 29, 2024 - (JCN Newswire) - Eisai Co., Ltd. announced today that drug discovery research conducted on lemborexant (brand name: Dayvigo), the...
Sino Biopharm (1177.HK) Announces 2023 Annual Results
HONG KONG, Mar 29, 2024 - (ACN Newswire) - Sino Biopharmaceutical Limited (“Sino Biopharm” or the “Company”, together with its subsidiaries, the “Group”) (HKEX:1177), a...
Latest Intelligence
